Experts say the financial crisis could affect Obama’s plans for healthcare reform.
WebMD Health News
Obama Wins: What It Means for Healthcare
Published in November 5th, 2008
Posted by Medscape Pharmacists Headlines in Drugs and Food Information, Health Information, Pharmaceutical Industry News
Comments Off
FDA Reports Nationwide Recall of Mislabeled ReliOn Insulin Syringes (November 5)
Published in November 5th, 2008
Comments Off
The U.S. Food and Drug Administration is notifying health care professionals and patients that Tyco Healthcare Group LP (Covidien) is recalling one lot of ReliOn sterile, single-use, disposable, hypodermic syringes with permanently affixed hypodermic needles due to possible mislabeling. The use of these syringes may lead to patients receiving an overdose of as much as 2.5 times the intended dose, which may lead to hypoglycemia, serious health consequences, and even death.
FDA Approvals: Vimpat and Stalevo
Published in November 5th, 2008
Posted by Medscape Pharmacists Headlines in Drugs and Food Information, Health Information, Pharmaceutical Industry News
Comments Off
The FDA has approved lacosamide as add-on therapy for partial-onset seizures and 2 new dosage strengths of a compound combining levodopa, carbidopa, and entacapone, indicated for Parkinson’s disease.
Medscape Medical News
FDA Approvals: Vimpat and Stalevo
Published in November 5th, 2008
Posted by Medscape Pharmacists Headlines in Drugs and Food Information, Health Information, Pharmaceutical Industry News
Comments Off
The FDA has approved lacosamide as add-on therapy for partial-onset seizures and 2 new dosage strengths of a compound combining levodopa, carbidopa, and entacapone, indicated for Parkinson’s disease.
Medscape Medical News
FDA Approvals: Vimpat and Stalevo
Published in November 5th, 2008
Posted by Medscape Pharmacists Headlines in Drugs and Food Information, Health Information, Pharmaceutical Industry News
Comments Off
The FDA has approved lacosamide as add-on therapy for partial-onset seizures and 2 new dosage strengths of a compound combining levodopa, carbidopa, and entacapone, indicated for Parkinson’s disease.
Medscape Medical News
FDA Approvals: Vimpat and Stalevo
Published in November 5th, 2008
Posted by Medscape Pharmacists Headlines in Drugs and Food Information, Health Information, Pharmaceutical Industry News
Comments Off
The FDA has approved lacosamide as add-on therapy for partial-onset seizures and 2 new dosage strengths of a compound combining levodopa, carbidopa, and entacapone, indicated for Parkinson’s disease.
Medscape Medical News
FDA Approvals: Vimpat and Stalevo
Published in November 5th, 2008
Posted by Medscape Pharmacists Headlines in Drugs and Food Information, Health Information, Pharmaceutical Industry News
Comments Off
The FDA has approved lacosamide as add-on therapy for partial-onset seizures and 2 new dosage strengths of a compound combining levodopa, carbidopa, and entacapone, indicated for Parkinson’s disease.
Medscape Medical News
FDA Safety Changes: Viread and Sustiva
Published in November 5th, 2008
Posted by Medscape Pharmacists Headlines in Drugs and Food Information, Health Information, Pharmaceutical Industry News
Comments Off
The FDA has approved revisions to the safety labeling for tenofovir disoproxil fumarate tablets (Viread) and efavirenz capsules and tablets (Sustiva).
Medscape Medical News
FDA Safety Changes: Viread and Sustiva
Published in November 5th, 2008
Posted by Medscape Pharmacists Headlines in Drugs and Food Information, Health Information, Pharmaceutical Industry News
Comments Off
The FDA has approved revisions to the safety labeling for tenofovir disoproxil fumarate tablets (Viread) and efavirenz capsules and tablets (Sustiva).
Medscape Medical News
FDA Safety Changes: Viread and Sustiva
Published in November 5th, 2008
Posted by Medscape Pharmacists Headlines in Drugs and Food Information, Health Information, Pharmaceutical Industry News
Comments Off
The FDA has approved revisions to the safety labeling for tenofovir disoproxil fumarate tablets (Viread) and efavirenz capsules and tablets (Sustiva).
Medscape Medical News